Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-03-10 @ 11:51 PM
Study NCT ID:
NCT02590627
Status:
COMPLETED
Last Update Posted:
2017-12-26
First Post:
2014-07-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure
Sponsor:
National Institute for Medical Research, Tanzania
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
WB-Malaria- Tanzania.
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None